Basic fibroblast growth factor sensitizes NIH 3T3 cells to apoptosis induced by cisplatin

Molecular Pharmacology

Volumn 57, Issue 2, 2000, Pages 324-333

  Coleman, Aaron B ^b   Momand, Jamil ^a,b   Kane, Susan E ^b  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CISPLATIN; FIBROBLAST GROWTH FACTOR RECEPTOR; SURAMIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; DOSE RESPONSE; DRUG RECEPTOR BINDING; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; DRUG INTERACTIONS; FIBROBLAST GROWTH FACTOR 2; MICE; RECEPTORS, FIBROBLAST GROWTH FACTOR; SURAMIN;

EID: 0033976369     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bikfalvi A, Klein S, Pintucci G, Quarto N, Mignatti P and Rifkin DB (1995) Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: Possible intracellular signaling by the high molecular weight forms. J Cell Biol 129:233-243.
2. Borsellino N, Belldegrun A and Bonavida B (1995) Endogenous interleukin 6 is a resistance factor for cis-diaminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines. Cancer Res 55:4633-4639.
3. CDC2 in HeLa cells. Cancer Res 57:1364-1370.
4. Cook PW, Ashton NM, Karkaria CE, Siess DC and Shipley GD (1995) Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity. J Cell Phys 163:418-429.
5. Evan G and Littlewood T (1998) A matter of life and cell death. Science 281:1317-1322.
6. Fan S, Smith ML, Rivet DJ, Duba D, Zhan Q, Kohn KW, Fornace AJ and O'Connor PM (1995) Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res 55:1649-1654.
7. Fenig E, Livnat T, Sharkon-Polak S, Wasserman L, Beery E, Lilling G, Yahalom J, Wieder R and Nordenberg J (1999) Basic fibroblast growth factor potentiates cisplatin-induced cytotoxicity in MCF-7 human breast cancer cells. J Cancer Res Clin Oncol 125:556-562.
8. Florkiewicz RZ, Majack RA, Buechler RD and Florkiewicz E (1995) Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/golgi pathway. J Cell Phys 162:388-399.
9. Florkiewicz RZ and Sommer A (1989) Human basic fibroblast growth factor gene encodes four polypeptides: Three initiate translation from non-AUG codons. Proc Natl Acad Sci USA 86:3978-3981.
10. Fox JC and Shanley JR (1996) Antisense inhibition of basic fibroblast growth factor induces apoptosis in smooth muscle cells. J Biol Chem 271:12578-12584.
11. Fuks Z, Persaud RS, Alfieri A, McLoughlin M, Ehleiter D, Schwartz JL, Seddon AP, Cordon-Cardo C and Haimovitz-Friedman A (1994) Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res 54:2582-2590.
12. Gospodarowicz D, Bialecki H and Thakral TK (1979) The angiogenic activity of the fibroblast and epidermal growth factor. Exp Eye Res 28:501-514.
13. Grothey A, Voigt W, Schober C, Muller T, Dempke W and Schmoll HJ (1999) The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors. J Cancer Res Clin Oncol 125:166-173.
14. Hawkins DS, Demers GW and Galloway DA (1996) Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res 56:892-898.
15. Horowitz A and Simons M (1998) Regulation of syndecan-4 phosphorylation in vivo. J Biol Chem 273:10914-10918.
16. Huang A, Jin H and Wright JA (1994) Aberrant expression of basic fibroblast growth factor in NIH-3T3 cells alters drug resistance and gene amplification potential. Exp Cell Res 213:335-339.
17. Johnson DE and Williams LT (1993) Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60:1-41.
18. Kalman D, Gomperts SN, Hardy S, Kitamura M and Bishop JM (1999) Ras family GTPases control growth of astrocyte processes. Mol Biol Cell 10:1665-1683.
19. Kato Y and Gospodarowicz D (1985) Sulfated proteoglycan synthesis by confluent cultures of rabbit costal chondrocytes grown in the presence of fibroblast growth factor. J Cell Biol 100:477-485.
20. Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I and Schlessinger J (1997) A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89:693-702.
21. Maloof P, Wang Q, Wang H, Stein D, Denny TN, Yahalom J, Fenig E and Wieder R (1999) Overexpression of basic fibroblast growth factor (FGF-2) downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res Treat 56:153-167.
22. Menzel T, Rahman Z, Calleja E, White K, Wilson EL, Wieder R and Gabrilove J (1996) Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. Blood 87:1056-1063.
23. Merrill GF (1998) Cell Synchronization. Methods Cell Biol 57:229-249.
24. Miyake H, Hara J, Gohji K, Yoshimura K, Arakawa S and Kamidono S (1998) Expression of basic fibroblast growth factor is associated with resistance to cisplatin in a human bladder cancer cell line. Cancer Lett 123:121-126.
25. Mohammadi M, Honegger AM, Rotin D, Fischer R, Bellot F, Li W, Dionne CA, Jaye M, Rubinstein M and Schlessinger J (1991) A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mol Cell Biol 11:5068-5078.
26. Moscatelli D (1987) High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Phys 131:123-130.
27. Ohgoh M, Kimura M, Ogura H, Katayama K and Nishizawa Y (1998) Apoptotic cell death of cultured cerebral cortical neurons induced by withdrawal of astroglial support. Exp. Neurol 149:51-63.
28. Saoncella S, Echtermeyer F, Denhez F, Nowlen JK, Mosher DF, Robinson SD, Hynes RO and Goetinck PF (1999) Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc Natl Acad Sci USA 96:2805-2810.
29. Shaulian E, Resnitzky D, Shifman O, Blandino G, Amsterdam A, Yayon A and Oren M (1997) Induction of Mdm2 and enhancement of cell survival by bFGF. Oncogene 15:2717-2725.
30. Spivak-Kroizman T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, Huang J, Jaye M, Crumley G, Schlessinger J and Lax I (1994) Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79:1015-1024.
31. Szebenyi G and Fallon JF (1999) Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytology 185:45-106.
32. Wang Q, Maloof P, Wang H, Fenig E, Stein D, Nichols G, Denny TN, Yahalom J and Wieder R (1998) Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells. Exp Cell Res 238:177-187.
33. Wieder R, Wang H, Shirke S, Wang Q, Menzel T, Feirt N, Jakubowski AA and Gabrilove JL (1997) Low level expression of basic FGF upregulates Bcl-2 and delays apoptosis, but high intracellular levels are required to induce transformation in NIH 3T3 cells. Growth Factors 15:41-60.
34. Yayon A and Klagsbrun M (1990) Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: Reversal by suramin. Pro Natl Acad Sci USA 87:5346-5350.